Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744523 · ClinicalTrials.gov registry record · NA
Proximal Protection With The Mo.Ma Device During Carotid Stenting
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT00744523 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 262 participants.
The verdict
NCT00744523, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid endarterectomy who undergo carotid artery stenting
Interventions
- DEVICE Mo.Ma cerebral protection device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744523
The ClinicalTrials.gov registry entry for NCT00744523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mo.Ma cerebral protection device is the first listed.
NCT00744523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744523 about?
NCT00744523 is a clinical study titled "Proximal Protection With The Mo.Ma Device During Carotid Stenting". The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid endarterectomy who undergo carotid artery stenting
What is the current status of trial NCT00744523?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2007-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00744523?
The interventions under investigation include: Mo.Ma cerebral protection device (DEVICE).
Who is sponsoring clinical trial NCT00744523?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.